Wholegrain Review Finds Modest Improvements in Heart Risk Markers

On 16 September 2026, the European Society of Cardiology reported on a systematic review and meta-analysis published in the European Heart Journal examining wholegrain intake and cardiovascular risk factors. Across 87 randomized trials involving 6,529 participants, the analysis found improvements in several measures of cardiovascular and metabolic health.

The Findings Reinforce Existing Dietary Advice

Wholegrains already had a place in cardioprotective dietary guidance. The accompanying European Heart Journal editorial, summarized by the European Society of Cardiology, argued that these findings do not necessarily require major changes to current guidelines.

Instead, the editorial supported helping people move toward the higher end of existing wholegrain targets. Study author Dr Helda Tutunchi said the analysis aimed to clarify intake levels because earlier clinical trials had produced mixed findings.

The update is therefore about strengthening the evidence behind familiar food advice. It is not a reversal from a medical consensus that grain foods should be avoided. For women navigating weight and nutrition questions in midlife, that distinction keeps the finding separate from another restrictive diet message.

The Trials Found Improvements Across Several Risk Factors

The European Society of Cardiology’s summary describes a pattern of changes across several markers rather than one standout result:

• The research brought together trials from several regions. The studies were conducted in Asia and Europe, the United States and Canada, plus Australia and Brazil. This was a review of randomized controlled trials testing wholegrain intake rather than a single study observing people’s usual eating habits. Its contribution was to examine the combined evidence and look for a relationship between intake and changes in cardiometabolic markers.
• The findings extended beyond cholesterol. The ESC reported improvements in body weight and waist circumference, total cholesterol, LDL cholesterol and triglycerides. Improvements were also reported in systolic blood pressure, fasting glucose and insulin resistance. Interleukin-6, a marker of inflammation, also decreased. These outcomes give the analysis relevance to several parts of metabolic health rather than just the number on a scale.
• Evidence certainty differed by outcome. Certainty was rated high for reductions in body weight, waist circumference, total cholesterol and interleukin-6. It was rated moderate for LDL cholesterol, triglycerides and systolic blood pressure. The same moderate rating applied to fasting plasma glucose and insulin resistance measured by HOMA-IR. Keeping those categories separate gives a more accurate account than describing every result as equally well established.
• The clearest overall intake pattern appeared around 60 to 100 grams daily by dry weight. According to the ESC, that corresponds to approximately four to six servings of wholegrain per day. The dose-response analysis also found benefits at approximately 30 to 40 grams per day by dry weight. The higher range describes where the overall pattern was clearest in this analysis, rather than a pass-or-fail boundary for healthy eating.
• Wholegrain refers to the grain’s structure. The accompanying editorial defines wholegrains as cereal grains retaining the bran, germ and endosperm in the same proportions as the intact kernel. They can be eaten as intact kernels or flakes, or as flour used in foods such as bread. The definition does not require every wholegrain food to look like an unbroken grain. That matters when translating a research term into ordinary food choices.

The Evidence Has Clear Boundaries

The ESC stressed that the trials measured risk factors rather than heart attacks or strokes. Their average duration was approximately eight weeks, so the analysis does not establish sustained weight change or whether the observed improvements lead to fewer cardiovascular events. The research was not limited to women in perimenopause or after menopause, so it does not establish a menopause-specific response.

Tutunchi also noted that relatively few studies examined intakes above 140 grams per day. The effects of very high intake remain uncertain. There is no sound basis here for assuming that eating progressively more wholegrain produces progressively greater benefit.

The serving description has a separate practical boundary: it refers to dry grain weight rather than the cooked food on a plate. A cooked portion of rice cannot simply be read as the same weight of dry wholegrain. The ESC release also does not describe one universal meal schedule or portion formula followed by every participant.

The observed changes in individual markers were modest. Responses may vary with the wider dietary pattern and health conditions. Medication use, energy needs and food tolerance also matter. Taken together, these limits make the findings useful for dietary context rather than a personal prescription.

Midlife Relevance Extends Beyond Weight

The National Lipid Association identifies cardiovascular health as a substantial concern for women after menopause. It notes that the rate of atherosclerotic cardiovascular disease in postmenopausal women can match or exceed that in men. It also describes cardiovascular disease as a major cause of illness and death among women worldwide.

That context explains why research on cholesterol, blood pressure and glucose deserves attention during midlife. A finding about food does not need to promise dramatic weight loss to be relevant to women’s health. Changes across several risk pathways may be more meaningful than treating any one food as a way to change body size.

For broader context, Refemina’s coverage of cardiovascular risk around the menopausal transition places nutrition within a wider health discussion. The practical question is how wholegrain foods fit into that picture, not whether they can carry the entire task of prevention.

Food Substitution Is the Practical Message

The editorial’s interpretation supports replacing refined grain foods with minimally processed wholegrain options. That is a different proposition from adding large amounts of grain food to an otherwise unchanged diet.

• Replacement is more useful than addition. The research-supported direction is toward wholegrain versions of some foods already being eaten. This keeps the emphasis on the dietary pattern rather than treating a serving count as something to add regardless of the rest of the day. For someone managing total energy intake, the distinction between a replacement and an addition is particularly relevant. The finding is about food choice within an overall pattern.
• The examples are familiar foods. The ESC points to oatmeal, a sandwich made with wholegrain bread and brown rice. These examples show how wholegrains can appear across ordinary meals without requiring a specialist product or a separate eating plan. They are illustrations of food types rather than a fixed menu. The study does not provide a reason to turn breakfast or lunch into a daily nutrition calculation.
• The whole product still matters. The editorial cautions that a food can contain wholegrain ingredients while remaining a highly processed product. It favors access to minimally processed wholegrain staples rather than treating a wholegrain label as proof that the product is broadly health-promoting. This is a useful distinction when nutrition marketing turns one ingredient into a promise about an entire food. The ingredient claim and the overall food choice are not interchangeable.

For women frustrated by changing weight or body composition, the calmer interpretation is that carbohydrate-containing foods do not automatically become inappropriate at menopause. The distinction supported here is between minimally processed wholegrain foods and refined or highly processed grain products. It is not a contest between eating grains and caring about metabolic health.

That perspective also leaves room for a broader discussion of muscle and body composition. The wholegrain finding belongs within that conversation rather than replacing it with another single-food answer.

Clinical Assessment Still Has Its Place

The ESC describes wholegrain intake as a strategy that can complement other lifestyle and medical interventions. For a woman with hypertension or diabetes, that means nutrition sits alongside appropriate clinical care. The same applies to high LDL cholesterol or established cardiovascular disease.

A new or worsening blood-pressure, cholesterol or glucose result deserves assessment rather than an attempt to manage it through food alone. A qualified clinician can interpret those results and discuss whether medication or individualized dietary advice is needed. The useful role of this research is to give that conversation a clearer food-based option, not to make medical care seem unnecessary.

This also changes how the headline should be read. Four to six servings is a research summary that needs context. It is not a promise of rapid weight loss or a reason to buy a supplement marketed around the same finding.

Wholegrains Have a Supportive Clinical Role

This analysis supports a more concrete place for minimally processed wholegrains in clinical nutrition conversations, alongside assessment and treatment of a woman’s wider cardiovascular risk.

How Refemina helps

Daily wholegrain decisions sit with the woman planning her meals; Refemina brings research-led context to those choices. For readers facing heart-health claims packaged as weight-loss or supplement opportunities, its editorial focus connects nutrition with hormonal change and body composition to support a more informed understanding of midlife health.

Explore Resources

Sources

1. Four to six servings of wholegrain per day lowers risk factors for ...
2. Lipoprotein(a) and ASCVD Risk in Women | NLA